Pfizer and Arvinas have axed two phase 3 trials from their estrogen receptor (ER) degrader R&D plan in the wake of mixed data. Arvinas disclosed the rethink alongside news that it is laying off ...

Shares of Arvinas fell after the biotechnology company ended plans for two Phase 3 trials as part of its collaboration with Pfizer, and said that it would cut about a third of its workforce.

In July 2021, Arvinas announced a global collaboration with Pfizer for the co-development and co-commercialization of vepdegestrant; Arvinas and Pfizer will share worldwide development costs ...

1Q 2025 Business Highlights and Recent Developments Vepdegestrant: Oral PROTAC ER degrader: As part of Arvinas global collaboration with Pfizer, the companies: Reported positive topline data for ...

Arvinas Inc (NASDAQ:ARVN) aligned with Pfizer to remove two phase 3 combination trials from their joint development plan, potentially limiting future combination therapy options. The company ...

1Q 2025 Business Highlights and Recent Developments Vepdegestrant: Oral PROTAC ER degrader: As part of Arvinas global collaboration with Pfizer, the companies: Reported positive topline data for ...

Detailed price information for Arvinas Inc (ARVN-Q) from The Globe and Mail including charting and trades.

In July 2021, Arvinas announced a global collaboration with Pfizer for the co-development and co-commercialization of vepdegestrant; Arvinas and Pfizer will share worldwide development costs, ...

May 01, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq ... we and our partners at Pfizer have removed plans for a Phase 3 first-line combination trial with atirmociclib, as well as the planned ...

Similarly, BTIG reduced its price target to $16 from $69, maintaining a Buy rating, after Arvinas and Pfizer decided to discontinue Phase 3 trials for combination therapies, influenced by limited ...

We and Pfizer will continue to evaluate our ongoing ... I also want to thank the employees who are continuing the journey with [Arvinas], as each of them will be instrumental in helping us achieve ...